Related Experiment Video

Updated: Oct 12, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.9K

Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy

Jingyao Cui1, Haoran Chen1, Kaiwen Zhang1

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.

Journal of Molecular Medicine (Berlin, Germany)
|November 25, 2021
PubMed

Insights

Targeting the Wnt pathway offers a promising therapeutic strategy for breast cancer bone metastasis, addressing limitations of traditional treatments. This review explores pharmacological Wnt modulators and future directions for bone metastasis intervention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteolytic bone destruction affects ~60% of advanced breast cancer patients.
  • The exact pathogenesis of bone metastasis remains unclear, limiting traditional antiresorptive therapies.
  • The Wnt pathway plays a crucial role in multiple stages of cancer bone metastasis.

Purpose of the Study:

  • To review current pharmacological Wnt modulators for breast cancer bone metastasis.
  • To discuss emerging Wnt pathway-targeted therapies for bone metastasis.
  • To highlight opportunities for Wnt pathway-based therapeutic development.

Main Methods:

  • Literature review of Wnt pathway modulators.
  • Analysis of therapeutic strategies targeting Wnt signaling in bone metastasis.
  • Exploration of Wnt pathway's role in bone metastasis pathology.

Main Results:

  • Pharmacological Wnt modulators show promise in treating breast cancer bone metastasis.
  • Emerging strategies focus on Wnt pathway-related targets for bone therapy.
  • Understanding Wnt pathway implications can guide new intervention strategies.

Conclusions:

  • The Wnt pathway is a key target for novel breast cancer bone metastasis treatments.
  • Targeted Wnt modulation offers potential advantages over traditional therapies.
  • Further research into Wnt signaling can lead to improved therapeutic interventions.
Keywords:
Bone homeostasisBone pathologyBone therapeuticsBreast cancer bone metastasisWnt pathway

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.5K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

5.6K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K